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Summary The SARS-CoV-2 infection, which causes the COVID-19 disease, has impacted every nation on the
globe, albeit disproportionately. African countries have seen lower infection and mortality rates than
most countries in the Americas Europe and Asia. In this commentary, we explore some of the factors
purported to be responsible for the low COVID-19 infection and case fatality rates in Africa: low
testing rate, poor documentation of cause of death, younger age population, good vitamin D status as
a result of exposure to sunlight, cross-immunity from other viruses including coronaviruses, and
lessons learnt from other infectious diseases such as HIV and Ebola. With the advent of a new
variant of COVID-19 and inadequate roll-out of vaccines, an innovative and efficient response is
needed to ramp up testing, contact tracing and accurate reporting of infection rates and cause of
death in order to mitigate the spread of the infection.
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The severe acute respiratory syndrome coronavirus
(SARS-CoV-2) infection, which causes the coronavirus
disease of 2019 (COVID-19), is a serious threat to global
health, economy and security. The Americas, Europe and
Asia have greater burdens of COVID-19-confirmed cases
and higher mortality rates than the African continent [1].
As of 19 January 2021[1], Africa had reported
3 309 919 cases and 80 939 COVID-19-related deaths
vs. 954 545 deaths in Americas, 666 237 in Europe and
191 196 in Asia [2]. Several factors such as socio-demo-
graphic characteristics and comorbidity have been corre-
lated with COVID-19 hospitalisation and death globally
[3–5]. Becuase Africa bears a huge burden of HIV, tuber-
culosis and non-communicable diseases, in the backdrop
of socioeconomic determinants of poor health and
deplorable healthcare systems, increased death from
COVID-19 infection was anticipated.
However, in several African countries, infection rates
and case fatalities have not matched expectations, partic-
ularly considering the continent’s generally fragile health-
care systems. Several hypotheses are currently being
explored to explain why Africa seems to have
comparatively lower COVID-19 infection and case fatal-
ity rates [6–9]. The testing rate in the African continent
of 1.3 billion inhabitants is among the lowest in the
world [8, 9], and most infected individuals never get
tested due to poor access to healthcare and testing ser-
vices. COVID-19 testing differs from country to country
based on several criteria. In most African countries, only
travellers into the country who present with COVID-19
symptoms, individuals with direct contact with positive
cases, and inhabitants of high-incidence areas are targeted
for testing. COVID-19 testing is less common than in
other regions, which may be masking its true spread [9].
South Africa is the only African country that has con-
ducted over 7 million COVID-19 tests [10]. In Nigeria,
just over one million samples had been tested by January
2021 – a country of more than 200 million inhabitants
[10]. In Cameroon, only 781,000 tests had been done as
of 31 December 2020 [11]. Ghana had tested only
710,137 as of January 2021 [10]. In some African coun-
tries, there are insufficient or no data available on testing
to know the actual number [9], indicating that little
effort and few resources are directed towards COVID-19
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testing. It is obvious that there is underreporting of the
total burden of COVID-19 in Africa. When there is an
outbreak, even on a small scale, hospitals are over-
whelmed.
An estimate of the true human life impact of COVID-
19 requires the reporting of COVID-19-related deaths.
Vital statistics such as death registration and the process-
ing of administrative data are a big challenge in Africa.
Findings from a recent survey conducted by the Eco-
nomic Commission of Africa (ECA) indicate that only
one in three deaths is captured by official registration sys-
tems, and of the 54 African countries, only 18 countries
record and report annual deaths [12]. Worse still, only
four countries document the cause of death and have a
level of death registration coverage that meets interna-
tional standards [13]. South Africa is one of the few Afri-
can nations that is generating vital statistics from the
civil registration system [14]. A report by the South Afri-
can Medical Research Council shows an excess death of
125 744 between May 2020 and January 2021, indicat-
ing that the number of people who have died from
COVID-19 could have been underestimated [15]. In
Nigeria and most other African countries, death registra-
tion is rare [12, 13, 16], leading to the underestimation
of death rates. A recent systematic review of the perfor-
mance and challenges of death registration in Nigeria
indicates that only 10% of deaths were registered in
2017 [16]. No mortality data were reported for Nigeria
in the WHO database between 2008 and 2017 [16]. In
June 2020, unusual deaths were reported in the northern
part of the country without establishing their cause. The
Nigerian Minister of Health indicated that half of these
deaths were most likely due to COVID-19 [17]. Recent
systematic post-mortem surveillance among 364 deceased
individuals in Zambia shows that 19.2% were infected
with COVID-19 and had died prior to reaching hospital
without being tested [18]. COVID-19 tracking and
reporting systems are conspicuously absent in Africa.
Africa’s young population has been highlighted as one
of the foremost reasons for the lower-than-expected
COVID-19 mortality rates [8, 9]. The median age is 19.4
years; 62% of the population are under the age of 25
years and only 3% are 65 years or older, whereas in the
USA and Europe 18% are 65 or older and 28% are
under 25. In South Africa, adults aged 30-39 have the
largest number of cases of COVID-19 [19]; in Nigeria, it
is adults aged 31-40 [20]. Most individuals with COVID-
19 in Nigeria are asymptomatic [21], resulting in a low
case fatality rate. Since the majority of the African popu-
lation are youth, there might be more infections but they
will mostly be mild or asymptomatic and most likely go
undetected.
COVID-19 is more commonly fatal in the elderly and
those with comorbidities [3–5,22], in the African region
and in the Americas, Europe and Asia [3, 5, 23]. Surpris-
ingly, there was less transmission of COVID-19 among
the elderly in African countries [24, 25]. Life expectancy
is much lower in Africa – 62 years for men and 65 years
for women – than in the USA, Europe and Asia, where life
expectancy is 71-77 years for men and 75-82 years for
women [26]. Africa’s life expectancy is less than the mean
age of COVID-19 fatalities in Italy in Europe; so it may
not have the most vulnerable age group for COVID-19 to
exert its effects to the fullest. However, the Africa Center
for Disease Control indicates that 20 of 55 countries have
case fatality rates higher than the global average of 2.2%
as of January 2021 [9], thus revealing that case fatality
rates have risen since the first wave of the pandemic [9].
People who had severe COVID-19 disease and poor
outcomes were lacking vitamin D and zinc [27, 28].
Recent studies have shown that sunlight, a major source
of vitamin D, influences COVID-19 infection and mortal-
ity rates [29–31]. Thus, the strong exposure to sunlight
in African countries may also contribute to lower case
fatalities compared to countries in other continents.
Lessons learned from the public health response to
other deadly infectious diseases such as Ebola haemor-
rhagic fever, Lassa fever and HIV epidemics may have
helped to mitigate the spread of COVID-19 in Africa. Fur-
thermore, cross-immunity from other coronaviruses has
been proposed as one of the reasons for the low case fatal-
ity rates [9] and relatively mild effects of the COVID-19
pandemic in Africa. It is noteworthy that the presence of
antibodies in the blood of patients infected with different
types of human coronaviruses has not been extensively
studied. However, subjects who had COVID-19 infection
developed antibodies to endemic human coronaviruses
[32], and the blood of recovered COVID-19 patients con-
tained neutralising antibodies that inhibit the entry of
SARS-CoV-2 in cells in vitro [33]. Hence, cross-reactive
antibodies generated as a result of infections from other
human coronaviruses might play a protective role in a
population affected by COVID-19. However, we strongly
believe that several other biological and environmental
factors also contribute significantly to this process.
Despite donations from the International Monetary
Fund, Bill and Melinda Gates Foundation and several
international organisations to support low- and middle-
income countries, access to COVID-19 test kits remains
insufficient [7], which means that in Africa the spread of
the COVID-19 cannot be effectively tracked. This is a
risk because of the recently detected highly transmissible
variant. Currently, several African countries are seeing an
increase in cases due to super spreader gatherings during
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the December holidays and other festive ocasions [9].
Another risk is that very little vaccine is available in
Africa, while the USA, Europe and some of Asia have
secured vaccines for their populations.
Most African countries face difficult choices regarding
disease mitigation strategies. Even though they have
shown an impressive level of responsiveness to the
COVID-19 pandemic during the first wave [34], effective
management of the pandemic remains a cause for con-
cern given the limited resources, fragile health systems,
insufficient testing, poor contact tracing and the existing
burden of disease [22, 34, 35]. With the new variant of
COVID-19, slow roll-out of vaccine and curative treat-
ment for COVID-19, a focus on testing and improved
reporting systems including proper documentation of the
cause of death is needed. Innovative strategies for
improving routine data information systems could enable
a more accurate understanding of the actual infection
and mortality rate in Africa to help mitigate the spread
and mortality of COVID-19. Further comprehensive stud-
ies are needed to elucidate the factors influencing the low
infection and mortality rate of COVID-19 in Africa.
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